77% of men survive soft tissue sarcoma for at least one year, and this falls to 55% surviving for five years or more, as shown by relative survival for patients diagnosed with soft tissue sarcoma during 2001-2009 in the UK.[1] Survival for women is lower, with 73% surviving for one year or more, and 52% surviving for at least five years.
Soft Tissue Sarcoma Age-Standardised One-, Five- and Ten-Year Relative Survival, Adults (Aged 15-85+), UK, 1996-2009
Ad Hoc Sex | 1-Year Survival (%) (2005-2009) | 5-Year Survival (%) (2001-2005) | 10-Year Survival (%) (1996-2000) | |
Men | Relative survival | 77.0 | 55.0 | 46.0 |
95% LCL | 76.0 | 54.0 | 44.0 | |
95% UCL | 78.0 | 57.0 | 48.0 | |
Women | Relative survival | 73.0 | 52.0 | 43.0 |
95% LCL | 72.0 | 51.0 | 42.0 | |
95% UCL | 74.0 | 53.0 | 45.0 | |
Adults | Relative survival | 75.0 | 53.0 | 45.0 |
95% LCL | 74.0 | 52.0 | 43.0 | |
95% UCL | 76.0 | 54.0 | 46.0 |
Five- and ten-year survival is predicted using an excess hazard statistical model.
Soft tissue sarcoma survival continues to fall beyond five years after diagnosis. 46% of men and 43% of women survive their disease for ten years or more, as shown by age-standardised relative survival for patients diagnosed with soft tissue sarcoma during 1996-2000 in the UK.[1]
About this data
Data is for: UK, 1996-2009. See source for ICD codes and other data specifics.